Literature DB >> 1348092

Prenatal prediction of Werdnig-Hoffmann disease using linked polymorphic DNA probes.

J Melki1, S Abdelhak, P Burlet, V Raclin, J Kaplan, R Spiegel, S Gilgenkrantz, N Philip, M L Chauvet, Y Dumez.   

Abstract

Werdnig-Hoffmann disease is a common autosomal recessive neuromuscular disorder that results in paralysis and death. No treatment to prevent this disease or to alter its unremitting course has been found. Recently, linkage analysis with cloned DNA probes has shown that the mutation causing Werdnig-Hoffmann disease is located on chromosome 5q12-q14. We performed genetic analysis for the prenatal diagnosis of Werdnig-Hoffmann disease in seven at risk families. Two fetuses were diagnosed as being affected and the remainder as unaffected, and this was confirmed after birth. This study shows that prenatal diagnosis of Werdnig-Hoffmann disease has become feasible.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348092      PMCID: PMC1015891          DOI: 10.1136/jmg.29.3.171

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  11 in total

1.  Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q.

Authors:  J Melki; S Abdelhak; P Sheth; M F Bachelot; P Burlet; A Marcadet; J Aicardi; A Barois; J P Carriere; M Fardeau
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

2.  Altered sodium channel behaviour causes myotonia in dominantly inherited myotonia congenita.

Authors:  P A Iaizzo; C Franke; H Hatt; W Spittelmeister; K Ricker; R Rüdel; F Lehmann-Horn
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

3.  Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3.

Authors:  L M Brzustowicz; T Lehner; L H Castilla; G K Penchaszadeh; K C Wilhelmsen; R Daniels; K E Davies; M Leppert; F Ziter; D Wood
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

4.  Classification of spinal muscular atrophies.

Authors:  J Pearn
Journal:  Lancet       Date:  1980-04-26       Impact factor: 79.321

5.  Chronic proximal spinal muscular atrophy of childhood and adolescence: problems of classification and genetic counselling.

Authors:  I Hausmanowa-Petrusewicz; J Zaremba; J Borkowska
Journal:  J Med Genet       Date:  1985-10       Impact factor: 6.318

Review 6.  The nosology of the spinal muscular atrophies.

Authors:  A E Emery
Journal:  J Med Genet       Date:  1971-12       Impact factor: 6.318

7.  Selective and nonselective susceptibility of muscle fiber types. A new approach to human neuromuscular diseases.

Authors:  W K Engel
Journal:  Arch Neurol       Date:  1970-02

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Genetic homogeneity between acute and chronic forms of spinal muscular atrophy.

Authors:  T C Gilliam; L M Brzustowicz; L H Castilla; T Lehner; G K Penchaszadeh; R J Daniels; B C Byth; J Knowles; J E Hislop; Y Shapira
Journal:  Nature       Date:  1990-06-28       Impact factor: 49.962

10.  Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators.

Authors:  J Melki; P Sheth; S Abdelhak; P Burlet; M F Bachelot; M G Lathrop; J Frezal; A Munnich
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

View more
  4 in total

1.  Apparent SMA I unlinked to 5q.

Authors:  J M Cobben; H Scheffer; M de Visser; J H Begeer; W M Molenaar; G van der Steege; C H Buys; G J van Ommen; L P Ten Kate
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

2.  Efficacy and Safety of Valproic Acid for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis.

Authors:  Abdelrahman Elshafay; Truong Hong Hieu; Mohamed Fahmy Doheim; Mahmoud Attia Mohamed Kassem; Mohammed Fathi ELdoadoa; Sarah Keturah Holloway; Heba Abo-Elghar; Kenji Hirayama; Nguyen Tien Huy
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

3.  Confirmation of clinical diagnosis in requests for prenatal prediction of SMA type I.

Authors:  J M Cobben; M de Visser; H Scheffer; J Osinga; G van der Steege; C H Buys; G J van Ommen; L P ten Kate
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

4.  Neonatal spinal muscular atrophy with diaphragmatic paralysis is unlinked to 5q11.2-q13.

Authors:  G Novelli; F Capon; L Tamisari; E Grandi; C Angelini; P Guerrini; B Dallapiccola
Journal:  J Med Genet       Date:  1995-03       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.